US Stem Cell Inc (USRM)
0.00
USD |
OTCM |
May 17, 16:00
US Stem Cell Total Liabilities (Quarterly): 14.81M for Dec. 31, 2022
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 14.81M |
| September 30, 2022 | 14.37M |
| June 30, 2022 | 13.93M |
| March 31, 2022 | 13.51M |
| December 31, 2021 | 12.82M |
| September 30, 2021 | 12.42M |
| June 30, 2021 | 12.08M |
| March 31, 2021 | 11.77M |
| December 31, 2020 | 11.67M |
| September 30, 2020 | 11.30M |
| June 30, 2020 | 10.41M |
| March 31, 2020 | 9.933M |
| December 31, 2019 | 9.569M |
| September 30, 2019 | 9.770M |
| June 30, 2019 | 8.555M |
| March 31, 2019 | 8.348M |
| December 31, 2018 | 8.699M |
| September 30, 2018 | 9.106M |
| June 30, 2018 | 9.248M |
| March 31, 2018 | 8.792M |
| December 31, 2017 | 8.698M |
| September 30, 2017 | 9.236M |
| June 30, 2017 | 8.770M |
| March 31, 2017 | 8.901M |
| December 31, 2016 | 8.446M |
| Date | Value |
|---|---|
| September 30, 2016 | 9.153M |
| June 30, 2016 | 7.911M |
| March 31, 2016 | 8.121M |
| December 31, 2015 | 7.951M |
| September 30, 2015 | 8.982M |
| June 30, 2015 | 9.438M |
| March 31, 2015 | 11.10M |
| December 31, 2014 | 11.10M |
| September 30, 2014 | 11.06M |
| June 30, 2014 | 10.63M |
| March 31, 2014 | 12.46M |
| December 31, 2013 | 13.83M |
| September 30, 2013 | 13.72M |
| June 30, 2013 | 14.04M |
| March 31, 2013 | 14.39M |
| December 31, 2012 | 14.76M |
| September 30, 2012 | 13.95M |
| June 30, 2012 | 12.84M |
| March 31, 2012 | 12.54M |
| December 31, 2011 | 12.28M |
| September 30, 2011 | 12.64M |
| June 30, 2011 | 13.06M |
| March 31, 2011 | 12.68M |
| December 31, 2010 | 12.32M |
| September 30, 2010 | 13.46M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
8.555M
Minimum
Jun 2019
14.81M
Maximum
Dec 2022
11.80M
Average
11.77M
Median
Mar 2021
Total Liabilities (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 9.147M |
| Perspective Therapeutics Inc | 48.40M |
| Protalix BioTherapeutics Inc | 60.04M |
| Electromed Inc | 6.357M |
| Armata Pharmaceuticals Inc | 176.87M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.068M |
| Shareholders Equity (Quarterly) | -14.75M |